Effect of Tetanus-diphtheria vaccine in promotion of immune response against hepatitis B vaccine
Phase 3
- Conditions
- Hepatitis B.Chronic viral hepatitis
- Registration Number
- IRCT2014051015999N2
- Lead Sponsor
- Vice Chancellor for Research Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 280
Inclusion Criteria
Inclusion Criteria: Individuals being Hepatitis B Antigen (HBsAg) negative whilst they were vaccinated against B hepatitis and their antibody titers would be lower than 100 IU/ml. Lack of primary or acquired immune deficiency
Exclusion criteria: Individuals will be excluded from the study and they will be treated if their status of hypersensitivity is recognized.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hepatitis B Antibody titer. Timepoint: 1 and 6 months after vaccination. Method of measurement: By ELISA method.
- Secondary Outcome Measures
Name Time Method